stockrowAlign Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. (ALGN) Shares outstanding
Align Technology, Inc.'s shares outstanding at the end of fiscal 2025 was $72.6M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $71.0M. Over the past ten years it has ranged from $72.6M (fiscal 2025) to $81.8M (fiscal 2017) — the current reading is the lowest in ten years. Align Technology, Inc. ranks 20th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $72.6M | (3.21%) |
| FY2024 | $75.0M | (2.06%) |
| FY2023 | $76.6M | (2.36%) |
| FY2022 | $78.4M | (1.57%) |
| FY2021 | $79.7M | 0.56% |
| FY2020 | $79.2M | (1.09%) |
| FY2019 | $80.1M | (1.55%) |
| FY2018 | $81.4M | (0.58%) |
| FY2017 | $81.8M | 0.43% |
| FY2016 | $81.5M | (0.05%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $71.0M | (0.71%) |
| Jun 2026 | $71.5M | (0.13%) |
| Mar 2026 | $71.6M | (1.34%) |
| Dec 2025 | $72.6M | 0.23% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $680.9M |
| BAX Baxter International Inc. compare | $520.0M |
| BLCO Bausch + Lomb Corporation compare | $361.5M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $170.8M |
| ALGN Align Technology, Inc. | $71.0M |
| ATR AptarGroup, Inc. compare | $64.1M |
| RGEN Repligen Corporation compare | $56.6M |
| TFX Teleflex Incorporated compare | $43.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement